Please login to the form below

Not currently logged in
Email:
Password:

arthritis

This page shows the latest arthritis news and features for those working in and with pharma, biotech and healthcare.

Novartis agrees to help produce Roche’s repurposed COVID-19 drug

Novartis agrees to help produce Roche’s repurposed COVID-19 drug

Actemra/RoActemra (tocilizumab) is already approved to treat a number of inflammatory conditions, including rheumatoid arthritis, paediatric juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, giant cell arteritis and CAR-T

Latest news

More from news
Approximately 97 fully matching, plus 657 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 58 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 10 fully matching, plus 29 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics